Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc.
Your view on LRMR
Overview
What the company does, where it operates, and who runs it.
About Larimar Therapeutics, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Carole S. Ben-Maimon
- Headquarters
- Three Bala Plaza East, Bala Cynwyd, PA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Carole S. Ben-Maimon
- Headquarters
- Three Bala Plaza East, Bala Cynwyd, PA, US
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.